Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$386K Buy
+3,000
New +$351K 0.01% 634
2025
Q4
Sell
-33,684
Closed -$2.83M 878
2025
Q3
$2.83M Buy
33,684
+10,969
+48% +$903K 0.12% 192
2025
Q2
$1.8M Sell
22,715
-69,080
-75% -$5.49M 0.08% 268
2025
Q1
$8.24M Buy
+91,795
New +$8.57M 0.35% 58

Other funds holding MRK

SummitTX Capital's MRK Position: Q2 2026 in Review

SummitTX Capital opened a new position in Merck (MRK) in Q2 2026: 3,000 shares worth $386K. The stake represents 0.01% of the portfolio and ranks #634 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in MRK as recently as Q3 2025.

SummitTX Capital first reported a position in MRK in Q1 2025 and has held it in 4 quarters since. The position peaked at $8.24M in Q1 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SummitTX Capital held 3,000 shares of Merck worth $386K as of Q2 2026.
  • Merck was a new SummitTX Capital position in Q2 2026.
  • Merck made up 0.01% of SummitTX Capital's portfolio in Q2 2026, its #634 holding.
  • SummitTX Capital first reported a position in Merck in Q1 2025 and has held it in 4 quarters since.
  • SummitTX Capital's Merck position peaked at $8.24M in Q1 2025.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.